NEFL and Brain atrophy: In MS, there is evidence that serum NfL (sNfL) levels correlate with CSF NfL, are associated with clinico‐radiological inflammatory disease activity, disability progression, and brain atrophy, and are modulated by disease‐modifying therapies (DMTs).3, 5, 6, 7, 8, 9